Niepubliczny Zakład Opieki Zdrowotnej MED-LASER
- Address
- ul. Mlynska 14A, 20-406 Lublin, Poland
MED-LASER Dermatological Research Center
Niepubliczny Zakład Opieki Zdrowotnej MED-LASER is a specialized medical research facility dedicated to advancing dermatological care through participation in innovative clinical trials. The center focuses on evaluating novel therapeutic approaches for chronic skin conditions, with particular emphasis on moderate-to-severe plaque psoriasis and its long-term management.
- Long-term safety and efficacy studies for advanced psoriasis treatments
- Investigation of novel immunomodulatory therapies including BMS-986165
- Chronic dermatological conditions requiring extended monitoring protocols
The center demonstrates expertise in conducting multi-center extension studies that characterize the prolonged use of investigational medications. By participating in open-label trials, MED-LASER contributes valuable data on the long-term safety and tolerability profiles of emerging treatments for patients with challenging inflammatory skin diseases, supporting the development of more effective therapeutic options for individuals with persistent plaque psoriasis.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Incyte Corp.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Incyte Corp.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Niepubliczny Zakład Opieki Zdrowotnej MED-LASER
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | Dec 2019 | Jul 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide | 2 | Unknown | 2024-12-12 | 2025-09-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.